DRL launches Sevelamer Carbonate tabs in US
The tablets of 800 mg strength are available in the bottle count size of 270
Author
Bharat Biotech’s Typbar-TCV vaccine confirms high efficacy in TCV human challenge study
According to the trial’s results published in The Lancet, the vaccine turned out to be 87 per cent effective for infants, older…
Indian pharma’s aggregate growth expected to come down to single digit
According to ICRA, the downfall will be led by limited near-term FTF generic opportunities and pricing pressure on base business
Lupin receives FDA approval for generic Acticlate tablets
They are indicated in the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne
Mylan and Natsimbio in agreement for production of anti-HIV drugs in Russia
The agreement will help Natsimbio to produce a wide range of generics for HIV treatment
Hilleman Laboratories receives Indo-Swedish grant to oral cholera vaccine
The project is being jointly funded by DBT and Vinnova
Dr Reddy’s Srikakulam unit clears US FDA audit
US FDA issues an EIR to DRL's Srikakulam plant
Digital can help bridge the growth gap for Indian Pharma – EY Report
EYDI identifies the gaps as pharma companies navigate their digital journey
Glenmark Pharmaceuticals receives ANDA approval
Desonide lotion is used to treat inflammation and itchiness caused by skin irritation
Serum Institute’s vaccine demonstrates significant efficacy against severe Rotavirus Gastroenteritis
Indian Government orders the vaccine for use in Universal Immunization Programme